Belgium - Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry
Since 2014, Belgium Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry grew 9.3% year on year. At $3,043,879,424.39 Million PPP in 2019, the country was ranked number 6 comparing other countries in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry. Belgium is overtaken by Switzerland, which was number 5 with $5,040,677,150.71 Million PPP and is followed by South Korea with $1,800,532,171.69 Million PPP. United States ranked the highest with $70,565,318,932.39 Million PPP in 2019, that is an increase of 3.3% versus 2018. China, Japan and Germany respectively ranked number 2, 3 and 4 in this ranking. Iceland recorded the best 5 years average growth at +43.9% per year, while Lithuania recorded the worst performance at -42.6% per year.
Loading...
| Date | Million US Dollars PPP |
|---|---|
| 2019 | 3,043,879,424.39 |
| 2018 | 2,916,399,764.81 |
| 2017 | 2,881,496,189.42 |
| 2016 | 2,617,150,345.49 |
| 2015 | 1,989,836,533.17 |
How does Belgium rank in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry?
| # | 69 Countries | Million US Dollars PPP | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
70,565,318,932.39 | 2019 | +3.3 % | +4.5 % | View data | |
| 2 |
#2
China
|
13,956,388,273.35 | 2019 | +4.5 % | +6.1 % | View data | |
| 5 |
#5
Switzerland
|
5,040,677,150.71 | 2019 | +3.2 % | +3.8 % | View data | |
| 6 |
#6
Belgium
|
3,043,879,424.39 | 2019 | +4.4 % | +9.3 % | View data | |
| 7 |
#7
South Korea
|
1,800,532,171.69 | 2019 | +4.1 % | +6.9 % | View data | |